Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
knowmoremedia.com » PharmaGazette - Jul 14, 2008
Amgen Inc. (NASDAQ:AMGN) announced that its experimental drug denosumab demonstrated that it can prevent bone loss in men that are being treated with prostate cancer drugs which can cause osteoporosis. Results, based …
Also tagged: amgn, prostate cancer, amgen, osteoporosis, denosumab
knowmoremedia.com » Know More Media - Health Care / Pharmaceutical / Fitness - Jul 14, 2008
Amgen Inc. (NASDAQ:AMGN) announced that its experimental drug denosumab demonstrated that it can prevent bone loss in men that are being treated with prostate cancer drugs which can cause osteoporosis. Results, based …
Also tagged: amgn, prostate cancer, amgen, osteoporosis, denosumab
knowmoremedia.com » Know More Media - Health Care / Pharmaceutical / Fitness - Jun 30, 2008
KnowMoreMedia is proud to announce our partnership and sponsorship of BlogWorld Expo 2008. This is the 2nd annual BlogWorld Expo and it is being held Sept 20 - 21 at the Las Vegas Convention Center. BlogWorld Expo is …
Also tagged: kmm, blogworldexpo
knowmoremedia.com » PharmaGazette - Jun 30, 2008
KnowMoreMedia is proud to announce our partnership and sponsorship of BlogWorld Expo 2008. This is the 2nd annual BlogWorld Expo and it is being held Sept 20 - 21 at the Las Vegas Convention Center. BlogWorld Expo is …
Also tagged: kmm, blogworldexpo
knowmoremedia.com » Know More Media - Health Care / Pharmaceutical / Fitness - May 26, 2008
An early trial of a vaccine to treat prostate cancer looks to be safe and effective in a small sample of people. The vaccine in question works by activating the immune system in men with metastatic prostate cancer. The …
Also tagged: cancer, prostate cancer, vaccine research
knowmoremedia.com » PharmaGazette - May 26, 2008
An early trial of a vaccine to treat prostate cancer looks to be safe and effective in a small sample of people. The vaccine in question works by activating the immune system in men with metastatic prostate cancer. The …
Also tagged: cancer, prostate cancer
knowmoremedia.com » Know More Media - Health Care / Pharmaceutical / Fitness - May 23, 2008
A drug called Exforge, by pharmaceutical Novartis Ag, could help to significantly reduce high blood pressure in black patients. Using this drug reduces systolic blood pressure more than just amlodipine. Exforge is a …
Also tagged: hypertension, novartis, exforge
knowmoremedia.com » PharmaGazette - May 23, 2008
A drug called Exforge, by pharmaceutical Novartis Ag, could help to significantly reduce high blood pressure in black patients. Using this drug reduces systolic blood pressure more than just amlodipine. Exforge is a …
Also tagged: hypertension, novartis
knowmoremedia.com » PharmaGazette - Apr 1, 2008
Findings of Merck's two-year Phase lll study of taranabant, the investigational cannabinoid-1 receptor (CB1R) blocker, showed that patients had a statistically significant weight loss when combining the drug with diet …
Also tagged: merck, weight control, taranabant
knowmoremedia.com » PharmaGazette - Apr 1, 2008
Novartis’ new hypertension drug Lotrel proved to be so effective that a clinical trial was stopped early. The medication which combines two blood pressure medications is targeted to prevent heart attacks and strokes …
Also tagged: hypertension, high blood pressure, lotrel